Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders

Childhood neurotransmitter disorders are increasingly recognised as an expanding group of inherited neurometabolic syndromes. They are caused by disturbance in synthesis, metabolism, and homeostasis of the monoamine neurotransmitters, including the catecholamines (dopamine, norepinephrine, and epine...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, J., Heales, S. J. R., Kurian, M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102824/
https://www.ncbi.nlm.nih.gov/pubmed/25011953
http://dx.doi.org/10.1007/s40272-014-0079-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102824/
https://www.ncbi.nlm.nih.gov/pubmed/25011953
http://dx.doi.org/10.1007/s40272-014-0079-z

Ejemplares similares